Skip to main content
Erschienen in: Zeitschrift für Gerontologie und Geriatrie 8/2019

24.10.2019 | Original Contributions

Association between EU guidelines and vaccination in Germany between 2011 and 2017

How healthcare legislation of the EU has influenced access to vaccination for senior citizens in Germany since 2011

verfasst von: Benjamin Azadi, German Managed Care Association

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Every fourth citizen within the 28 European Union (EU) member states is over the age of 65 years. In connection with the increasing numbers of senior citizens, vaccinations have become even more important as preventive measures. Vaccines are an established preventive measure and help to ensure that many diseases no longer have a fatal outcome. With respect to the health economic as well as preventive advantages of vaccines, there is possibly a considerable benefit for the EU to support the vaccination program for older patients within the framework of the demographic shift. Since 2011 the EU addresses the demographic change and has thereby placed the possible chances and risks on the agenda.

Objective

By focussing on Germany as an EU member state, the question whether the EU guidelines had an influence on vaccination access for senior citizens in the years 2011–2017 was analyzed. It is discussed if a healthcare policy influence was pursued, regardless of not having a unified EU healthcare system.

Material and methods

The EUR-lex database was searched for relevant EU policies regarding vaccination and older patients between February 2011 and May 2017. Results were then discussed within four expert interviews, which were from industry, academia, politics and physician practice.

Results

Overall, four relevant EU policies since 2011 were selected. The discussion resolves that the initiative of the EU to promote the healthcare of senior citizens (EMA Geriatric Medicines Strategy) and the Clinical trials – Regulation EU from 2014 had a significant impact on vaccination access. Due to the EU national policies in Germany were initiated, which had an effect on national level to this specific risk group and vaccination access.

Conclusion

Other than expected, the EU has a passive influence on the healthcare policy transformation on a national level; however, it should be noted that initiatives in politics are always influenced by several impulses. Hereby, a deeper analysis should be considered, which includes the policy action campaigns by multinational stakeholders.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
4.
Zurück zum Zitat Baeyens J (2011) The European medicines agency discovers the geriatric patient. Drugs Aging 28(11):849–851CrossRef Baeyens J (2011) The European medicines agency discovers the geriatric patient. Drugs Aging 28(11):849–851CrossRef
14.
Zurück zum Zitat European Parliament, Council of the EU (2013) Decision on cross-border threats (1082/2013) European Parliament, Council of the EU (2013) Decision on cross-border threats (1082/2013)
16.
Zurück zum Zitat Földes ME (2016) Health Policy and health systems: a growing relevance for the EU in the context of the economic crisis. J Eur Integr 38(3):295–309CrossRef Földes ME (2016) Health Policy and health systems: a growing relevance for the EU in the context of the economic crisis. J Eur Integr 38(3):295–309CrossRef
17.
Zurück zum Zitat Greer SL (2006) Uninvited Europeanization: neofunctionalism and the EU in health policy. J Eur Public Policy 13(1):134–152CrossRef Greer SL (2006) Uninvited Europeanization: neofunctionalism and the EU in health policy. J Eur Public Policy 13(1):134–152CrossRef
18.
Zurück zum Zitat Greer SL, Fahy N, Elliott HA, Wismar M, Jarman H, Palm W (2014) Everything you always wanted to know about European Union health policies but were afraid to ask. Obs Stud Ser 34:1–131 Greer SL, Fahy N, Elliott HA, Wismar M, Jarman H, Palm W (2014) Everything you always wanted to know about European Union health policies but were afraid to ask. Obs Stud Ser 34:1–131
21.
Zurück zum Zitat Kostera T (2008) Europeanizing Healthcare: cross-border patient mobility and its consequences for the German and Danish Healthcare systems. Bruges Polit Res Pap 1(7):38 Kostera T (2008) Europeanizing Healthcare: cross-border patient mobility and its consequences for the German and Danish Healthcare systems. Bruges Polit Res Pap 1(7):38
22.
Zurück zum Zitat Martinsen DS, Vrangbaek K (2008) The Europeanization of health care governance: implementing the market imperatives of Europe. Public Adm 86(1):169–184CrossRef Martinsen DS, Vrangbaek K (2008) The Europeanization of health care governance: implementing the market imperatives of Europe. Public Adm 86(1):169–184CrossRef
24.
Zurück zum Zitat Requejo MT (2014) Cross-border healthcare in Spain and the implementation of the directive 2011/24/eu on the application of patient’s rights in cross-border healthcare. Eur J Health Law 21(1):79–96CrossRef Requejo MT (2014) Cross-border healthcare in Spain and the implementation of the directive 2011/24/eu on the application of patient’s rights in cross-border healthcare. Eur J Health Law 21(1):79–96CrossRef
27.
Zurück zum Zitat Vollaard H, Martinsen DS (2017) The rise of a European healthcare union. Comp Eur Polit 15(3):337–351CrossRef Vollaard H, Martinsen DS (2017) The rise of a European healthcare union. Comp Eur Polit 15(3):337–351CrossRef
Metadaten
Titel
Association between EU guidelines and vaccination in Germany between 2011 and 2017
How healthcare legislation of the EU has influenced access to vaccination for senior citizens in Germany since 2011
verfasst von
Benjamin Azadi, German Managed Care Association
Publikationsdatum
24.10.2019
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 8/2019
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-019-01638-9

Weitere Artikel der Ausgabe 8/2019

Zeitschrift für Gerontologie und Geriatrie 8/2019 Zur Ausgabe

Journal Club

Journal Club